Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 14, 2016 5:12 AM ET

Biotechnology

Company Overview of Glycoregimmune, Inc.

Company Overview

Glycoregimmune, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that is developed as an oral therapeutic for liver disease. The company was incorporated in 2009 and is based in San Diego, California.

8954 Rio San Diego Drive

Suite 102

San Diego, CA 92108

United States

Founded in 2009

Phone:

619-400-1171

Key Executives for Glycoregimmune, Inc.

Co-Founder, Chairman, Chief Executive Officer and President
Co-Founder, Chief Scientific Officer and Director
Senior Vice President of Clinical Development
Compensation as of Fiscal Year 2015.

Glycoregimmune, Inc. Key Developments

Glycoregimmune, Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 04:00 PM

Glycoregimmune, Inc. Presents at 8th Annual Biotech Showcase Investor Conference 2016, Jan-12-2016 04:00 PM. Venue: Parc 55 San Francisco, 55 Cyril Magnin Street, San Francisco, CA 94102, United States.

Glycoregimmune, Inc. Presents at 14th Annual BIO Investor Forum, Oct-20-2015 11:15 AM

Glycoregimmune, Inc. Presents at 14th Annual BIO Investor Forum, Oct-20-2015 11:15 AM. Venue: Parc 55 Hotel, San Francisco, California, United States.

Similar Private Companies By Industry

Company Name Region
Enobia Canada Limited Partnership United States
Ixion Biotechnology, Inc. United States
Advanced Microbial Services Inc. United States
Cytoprint Inc. United States
HydraDx, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 2, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Glycoregimmune, Inc., please visit www.gribio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.